Glucose Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The global glucose market in 2025 spans multiple segments including medical diagnostic devices, point-of-care testing, and industrial applications, collectively valued at approximately $55.88 billion. The blood glucose monitor segment alone is forecast to reach $25.4 billion by 2030, while the continuous glucose monitoring (CGM) U.S. market, valued at $3.7 billion in 2024, is expected to grow substantially. The industrial glucose market represents approximately $5 billion of the total market.

• •Total global glucose market valued at ~$55.88 billion in 2025
• •Projected to reach ~$84.4 billion by 2034 at 4.4% CAGR
• •Point-of-care glucose testing segment valued at ~$3.42 billion in 2025 with ~4.6% CAGR

Rising diabetes prevalence globally is the core driver, fueling demand for both self-monitoring devices and continuous glucose monitoring solutions. Technological advancements in minimally invasive and connected health devices are accelerating adoption rates across developed and emerging markets. Additionally, growing health consciousness and preventive care initiatives are expanding the addressable market for glucose-related products.

• •Rising global diabetes and prediabetes prevalence
• •Technological innovation in CGM and smart monitoring devices
• •Expanding healthcare access and preventive care spending in emerging economies

The market is segmented into self-monitoring blood glucose devices, continuous glucose monitoring systems, and industrial glucose products. North America dominates the CGM market, with the U.S. alone representing over $3.7 billion, while the Asia-Pacific region is expected to see the fastest growth due to rising diabetes rates and improving healthcare infrastructure.

• •Segments include SMBG devices, CGM systems, point-of-care testing, and industrial glucose
• •North America leads in CGM adoption and spending
• •Asia-Pacific is the fastest-growing regional market

What are the recent trends and outlook?

The blood glucose monitoring segment is expanding at a notably faster rate than the broader market, with a projected CAGR of 9.1% through 2030. Integration of glucose data with broader digital health ecosystems, including smart insulin delivery systems and telehealth platforms, is expected to drive the next phase of market evolution. Long-term growth will also be supported by aging populations, dietary health trends, and regulatory approvals for over-the-counter and advanced monitoring devices.

• •Blood glucose monitoring segment growing at ~9.1% CAGR, outpacing overall market
• •Convergence with digital health, telemedicine, and automated insulin delivery
• •Regulatory and reimbursement shifts supporting wider access to CGM devices